Related Experiment Videos
Brain tumors
K L Black1, J C Mazziotta, D P Becker
1Division of Neurosurgery, UCLA School of Medicine 90024-1749.
Abstract:
Recent advances in experimental tumor biology are being applied to critical clinical problems of primary brain tumors. The expression of peripheral benzodiazepine receptors, which are sparse in normal brain, is increased as much as 20-fold in brain tumors. Experimental studies show promise in using labeled ligands to these receptors to identify the outer margins of malignant brain tumors. Whereas positron emission tomography has improved the dynamic understanding of tumors, the labeled selective tumor receptors with positron emitters will enhance the ability to specifically diagnose and greatly aid in the pretreatment planning for tumors. Modulation of these receptors will also affect tumor growth and metabolism. Novel methods to deliver antitumor agents to the brain and new approaches using biologic response modifiers also hold promise to further improve the management of brain tumors.
Insights
Peripheral benzodiazepine receptor imaging shows promise for diagnosing and planning treatment for primary brain tumors. Targeting these receptors may also impact tumor growth and metabolism, improving patient outcomes.
Area of Science:
- Neuro-oncology
- Molecular imaging
- Experimental tumor biology
Background:
- Primary brain tumors present critical clinical challenges.
- Peripheral benzodiazepine receptors (PBRs) are significantly overexpressed in brain tumors compared to normal brain tissue.
- PBRs represent a potential biomarker for tumor detection and characterization.
Purpose of the Study:
- To explore the application of experimental tumor biology findings to clinical problems in primary brain tumors.
- To investigate the utility of targeting PBRs for improved diagnosis and treatment planning.
- To assess the potential of modulating PBRs for affecting tumor growth and metabolism.
Main Methods:
- Utilizing labeled ligands that selectively bind to PBRs.
- Employing positron emission tomography (PET) with radiolabeled tracers targeting PBRs.
- Investigating novel drug delivery systems and biologic response modifiers.
Main Results:
- PBR expression is increased up to 20-fold in brain tumors.
- Labeled ligands to PBRs show promise in identifying the margins of malignant brain tumors.
- PET imaging with targeted tracers can enhance diagnostic accuracy and pretreatment planning.
Conclusions:
- Targeting peripheral benzodiazepine receptors offers a promising avenue for the diagnosis and management of primary brain tumors.
- Positron emission tomography with labeled selective tumor receptor ligands can significantly aid in pretreatment planning.
- Further research into receptor modulation and novel therapeutic delivery holds potential for improving brain tumor treatment.